Mesoblast (MESO) Profit After Tax (2015 - 2023)
Mesoblast (MESO) reported Profit After Tax of -$142.2 million for Q2 2023, up 12.01% on a YoY basis from -$127.0 million in Q2 2022, and down 862.86% sequentially from $18.6 million in Q1 2023.
Mesoblast (MESO) Profit After Tax (2015 - 2023) Analysis & Trends
Mesoblast (MESO) has 9 years of Profit After Tax data on file, last reported at -$142.2 million in Q2 2023.
- For the quarter ending Q2 2023, Profit After Tax rose 12.01% year-over-year to -$142.2 million; the trailing twelve-month figure through Jun 2023 stood at -$82.1 million (up 10.36% YoY), and the FY2025 full-year result was -$102.1 million, down 16.13% from the prior year.
- Profit After Tax declined to -$142.2 million in Q2 2023, from $18.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $26.0 million in Q4 2021 to a low of -$161.7 million in Q2 2022.
- A 5-year average of -$22.1 million and a median of -$23.0 million in 2019 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 201.59% in 2021 and tumbled 630.69% in 2022, its largest moves.
- Tracing MESO's Profit After Tax over 5 years: stood at -$26.9 million in 2019, then advanced by 4.6% to -$25.6 million in 2020, then soared by 201.59% to $26.0 million in 2021, then slipped by 5.64% to $24.6 million in 2022, then slumped by 679.24% to -$142.2 million in 2023.
- Business Quant data shows MESO's Profit After Tax at -$142.2 million in Q2 2023, $18.6 million in Q1 2023, and $24.6 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -142.24 Mn |
| Mar 31, 2023 | 18.65 Mn |
| Dec 31, 2022 | 24.56 Mn |
| Sep 30, 2022 | 16.94 Mn |
| Jun 30, 2022 | -161.67 Mn |
| Mar 31, 2022 | 21.35 Mn |
| Dec 31, 2021 | 26.03 Mn |
| Sep 30, 2021 | 22.71 Mn |
| Jun 30, 2021 | -22.13 Mn |
| Mar 31, 2021 | -26.61 Mn |
| Dec 31, 2020 | -25.62 Mn |
| Sep 30, 2020 | -25.27 Mn |
| Jun 30, 2020 | -35.87 Mn |
| Mar 31, 2020 | -17.22 Mn |
| Dec 31, 2019 | -26.85 Mn |
| Sep 30, 2019 | 7.42 Mn |
| Jun 30, 2019 | -23.90 Mn |
| Mar 31, 2019 | -27.18 Mn |
| Dec 31, 2018 | -27.47 Mn |
| Sep 30, 2018 | 20.21 Mn |